tri Dr Maritza McIntyre appointed Chief Development Officer at StrideBio By www.pharmafile.com Published On :: Wed, 08 Apr 2020 16:36:52 +0000 StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will see Dr McIntyre oversea the translational development of the company’s research-stage gene therapy programs. This includes regulatory filings, initiating early clinical studies and starting Investigational New Drug enabling preclinical studies. read more Full Article Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
tri The Harms of Abortion Restrictions During the COVID-19 Pandemic By blog.petrieflom.law.harvard.edu Published On :: Fri, 01 May 2020 12:00:51 +0000 These policies restricting abortion are unlikely to conserve PPE, and more importantly, they mischaracterize the nature and importance of abortions. The post The Harms of Abortion Restrictions During the COVID-19 Pandemic appeared first on Bill of Health. Full Article Abortion Beatrice Brown Bioethics Health Law Policy Patient Care Pregnancy Public Health Resource Allocation Student Fellows Abortion Regulation Constitutional Rights Constitutionality coronavirus COVID-19 covid-19 resources Health Law health law policy Health Policy Liberty Personal Protective Equipment PPE public health Self-determination
tri EPS taps CluePoints for trial management solution By www.outsourcing-pharma.com Published On :: Mon, 27 Apr 2020 15:42:00 +0100 The Japanese pharma development firm will harness risk-based quality management solutions to help sponsors improve trial quality and safety. Full Article Clinical Development
tri Pharmaseal adds eTMF document storage to trial platform By www.outsourcing-pharma.com Published On :: Tue, 05 May 2020 12:48:00 +0100 The company has incorporated electronic trial master file document storage capabilities to its Engility clinical trial management platform. Full Article Clinical Development
tri Medidata analysis shows COVID-19 impact on trials By www.outsourcing-pharma.com Published On :: Tue, 05 May 2020 12:51:00 +0100 The companyâs global analysis from thousands of studies and sites indicates dramatic shifts in enrollment across several countries since the pandemic began. Full Article Clinical Development
tri ThoughtSphere lands patent for clinical trial data technology By www.outsourcing-pharma.com Published On :: Thu, 07 May 2020 14:23:00 +0100 The data management solution is designed to help sponsors and CROs manage data more effectively, increasing cost efficiency and effectiveness. Full Article Clinical Development
tri Believable Extraterrestrials By blogs.scientificamerican.com Published On :: Sat, 09 May 2020 13:00:00 GMT The 100th anniversary of astronomy’s “Great Debate” prompts thoughts on the hunt for life in the universe -- Read more on ScientificAmerican.com Full Article The Sciences Space
tri Majority of Americans Open to Clinical Trial Participation If Recommended by a Doctor, New Study Finds By www.acrohealth.org Published On :: Wed, 06 Sep 2017 17:35:42 +0000 WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) applauds Research!America for a recently released survey on the public’s perception of clinical trials.... Full Article News Press Releases
tri ACRO Testifies About Clinical Trials In New Jersey By www.acrohealth.org Published On :: Mon, 23 Oct 2017 22:32:04 +0000 Washington, DC – October 24, 2017 – On October 19 ACRO Executive Director Doug Peddicord, Ph.D., testified at a public hearing of... Full Article News Press Releases
tri ACRO offers unique insights on risk-based monitoring of clinical trials, calls for adoption of RBM as a best practice By www.acrohealth.org Published On :: Thu, 16 May 2019 19:01:42 +0000 Following meetings with then-Commissioner Scott Gottlieb and senior leadership from the Center for Drug Evaluation and Research on the role of CROs and technology companies in designing and implementing risk-based monitoring (RBM) of clinical trials, ACRO this week submitted extensive comments on recent FDA Guidance.Increasing the use of innovative RBM technologies helps make clinical trials safer, more efficient and higher quality. ACRO’s comments offer unique insights into the recent expansion of RBM implementation and call for further increasing the use of these oversight technologies. Full Article News Press Releases digital FDA oversight RBM Risk Based Montoring
tri Advancing the Adoption of Risk-Based Monitoring Strategies in Clinical Trials By www.acrohealth.org Published On :: Fri, 16 Aug 2019 16:01:14 +0000 On July 17, 2019, under cooperative agreement with the FDA, the Duke-Margolis Center for Health Policy (Duke Margolis) held a public workshop. The event, titled Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations, aimed to identify opportunities to improve Risk Based Monitoring (RBM) implementation and solicit stakeholder input on the challenges, barriers, and enablers that impact the successful adoption of RBM. Full Article News FDA RBM Risk Based Montoring
tri The world needs a coronavirus vaccine. But it will take time | Patrick Vallance By www.theguardian.com Published On :: 2020-04-19T14:33:51Z Any vaccine has to work, but it also has to be safe. Making it happen is one of the government’s biggest priorities• Patrick Vallance is the UK government chief scientific adviserCoronavirus – latest updatesSee all our coronavirus coverageCovid-19 has made fundamental and long-lasting changes to the way we live our lives, not just in the UK, but across the world.As we continue with social-distancing measures and deal with the most immediate issue of reducing the number of cases to protect the NHS and save lives, and keeping R, which is the average infection rate per person, below one, we also need to progress ways to tackle the disease in the longer term.The vaccines taskforce will be working in lockstep with the public and private sector Related: New UK taskforce to help develop and roll out coronavirus vaccine Continue reading... Full Article Coronavirus outbreak Pharmaceuticals industry Science UK news Drugs Vaccines and immunisation
tri Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial By www.pharmafile.com Published On :: Fri, 24 Apr 2020 11:29:51 +0000 Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage of the ongoing pandemic, has failed in its first randomised clinical trial, leaked data has revealed. Full Article coronavirus COVID-19 Gilead pharma remdesivir Research and Development Medical Communications
tri Phase 3 Libtayo monotherapy trial halted early due to strong benefit in advanced non-small cell lung cancer By www.pharmafile.com Published On :: Wed, 29 Apr 2020 11:49:31 +0000 A Phase 3 study of Sanofi and Regeneron’s Libtayo (cemiplimab) as a monotherapy for advanced or metastatic non-small cell lung cancer (NSCLC) has been stopped early after showing strong overall survival benefit, it has emerged. Full Article cancer Libtayo lung cancer Regeneron Research and Development Sanofi
tri Arizona GOP lawmakers and AAPS say hydroxychloroquine has 90% chance of helping COVID-19 patients, but data is not based on clinical trials By www.pharmafile.com Published On :: Wed, 29 Apr 2020 11:58:38 +0000 The Association of American Physicians and Surgeons (AAPS) wrote a letter to Republican Arizona Governor Doug Ducey urging the wider use of hydroxychloroquine, based on data they have collected. Full Article chloroquine hydroxychloroquine Research and Development
tri Novartis’ asthma triple heads CHMP’s latest meeting By www.pmlive.com Published On :: Tue, 05 May 2020 12:50:48 +0100 Eight new medicines recommended for approval Full Article
tri Coronavirus contact-tracing app trial to begin on the Isle of Wight By www.pmlive.com Published On :: Wed, 06 May 2020 12:06:00 +0100 Initial roll-out will see key workers utilise the app Full Article
tri US trials of Pfizer/BioNTech coronavirus vaccine start By www.pmlive.com Published On :: Wed, 06 May 2020 12:16:48 +0100 It is hoped that the drug may prevent COVID-19 Full Article
tri CBD Product - Patriot Hemp Company By www.flickr.com Published On :: Fri, 08 May 2020 11:07:04 -0700 The U.S. Food and Drug Administration posted a photo: This product is promoted with unapproved claims to prevent, treat, mitigate, or cure COVID-19. FDA warns consumers to avoid unproven and potentially unsafe products. See the Warning Letter for more information: CBD Product – Patriot Hemp Company: www.fda.gov/inspections-compliance-enforcement-and-crimin... More information is available at www.fda.gov/consumers/health-fraud-scams/fraudulent-coron... Photo by FDA's Office of Regulatory Affairs, Health Fraud Branch This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to FDA's Office of Regulatory Affairs, Health Fraud Branch is appreciated but not required. Full Article
tri Lannett to Be U.S. Distributor of Posaconazole Delayed-Release Tablets By www.thestreet.com Published On :: Wed, 28 Aug 2019 08:18:15 EDT Click to view a price quote on LCI. Full Article
tri Oxford COVID-19 vaccine programme opens for clinical trial recruitment By www.pharmanews.eu Published On :: Thu, 23 Apr 2020 10:00:00 +0200 University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19 have started screening healthy volunteers (aged 18-55) for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won’t be ready for some weeks still. Full Article Featured Research Research & Development
tri AstraZeneca and Saint Luke’s Mid America Heart Institute initiate Phase III DARE-19 trial with Farxiga in COVID-19 patients By www.pharmanews.eu Published On :: Fri, 24 Apr 2020 10:00:00 +0200 AstraZeneca and Saint Luke's Mid America Heart Institute have initiated a randomised, global Phase III trial to assess the potential of Farxiga (dapagliflozin) as a treatment in patients hospitalised with COVID-19 who are at risk of developing serious complications, such as organ failure. Full Article Featured AstraZeneca Business
tri Novartis announces plan to initiate clinical trial of canakinumab for patients with COVID-19 pneumonia By www.pharmanews.eu Published On :: Wed, 29 Apr 2020 10:00:00 +0200 Novartis announced plans to initiate a Phase III clinical trial to study canakinumab in patients with COVID-19 pneumonia. The CAN-COVID trial will examine the efficacy of utilizing canakinumab, an interleukin (IL)-1β blocker, to treat a type of severe immune overreaction called cytokine release syndrome (CRS) in people with COVID-19 pneumonia. Full Article Featured Novartis Business
tri India remains on USTR list of IP problem countries By www.thepharmaletter.com Published On :: Mon, 04 May 2020 16:58:00 +0100 India continues to be on the 'Priority Watch List' of the US Trade Representative (USTR) for lack of… Full Article Focus On/Generics/India/Intellectual property law/Legal/Patents & Trademarks/USA
tri Mallinckrodt’s INOmax successful in trial of neonates with pulmonary hypertension By www.thepharmaletter.com Published On :: Mon, 04 May 2020 17:20:00 +0100 UK-based Mallinckrodt Pharmaceuticals has ended a trial of INOmax (nitric oxide) gas early due to positive… Full Article Drug Trial/Inomax/Mallinckrodt/Nitric Oxide/Pharmaceutical/Research/Respiratory and Pulmonary/UK
tri Positive Phase III data for Lupin’s trichomoniasis candidate By www.thepharmaletter.com Published On :: Tue, 05 May 2020 11:03:00 +0100 India’s Lupin has announced positive top-line results from its pivotal Phase III clinical trial to… Full Article Antibiotics and Infectious diseases/Drug Trial/India/Lupin/Pharmaceutical/Research/Solosec/Symbiomix Therapeutics/Women's health
tri Latest data show Libtayo beneficial in BCC trial By www.thepharmaletter.com Published On :: Tue, 05 May 2020 16:32:00 +0100 Positive top-line data for a pivotal, single-arm, open-label trial of PD-1 inhibitor Libtayo (cemiplimab)… Full Article Biotechnology/Drug Trial/France/Immuno-oncology/Libtayo/Oncology/Regeneron Pharmaceuticals/Research/Sanofi/USA
tri Akebia soars on positive Ph III trial results for vadadustat By www.thepharmaletter.com Published On :: Tue, 05 May 2020 19:20:00 +0100 Shares of US biotech Akebia Therapeutics were up more than 35% at $11.72 by early afternoon today, after… Full Article Akebia Therapeutics/Biotechnology/Drug Trial/Nephrology and Hepatology/Research/USA/vadadustat
tri BRIEF—GSK completes sale of nutrition brands for £3.4 billion By www.thepharmaletter.com Published On :: Thu, 07 May 2020 10:44:00 +0100 GlaxoSmithKline has completed divestment of its Horlicks and other Consumer Healthcare nutrition products… Full Article Companies mergers and acquisitions/Deals/Financial/GlaxoSmithKline/India/Pharmaceutical/UK
tri Tribute to Michael Becker By www.biotechduediligence.com Published On :: Fri, 10 Jan 2020 02:38:51 GMT The world of biotech suffered a great loss in 2019 with the passing on Michael Becker. Be sure to take in the tributes to Michael from around the Twitterverse. [...] Full Article Uncategorized
tri Former Oak Ridge Complex Employee Pleads Guilty to Unlawful Disclosure of Restricted Atomic Energy Data By www.justice.gov Published On :: Mon, 26 Jan 2009 11:57:12 EST Roy Lynn Oakley, 67, a resident of Harriman, Tenn., pleaded guilty today in U.S. District Court in Knoxville, to count one of an indictment charging him with unlawful disclosure of Restricted Data under the Atomic Energy Act, in violation of 42 U.S.C., Section 2274(b). Full Article OPA Press Releases
tri Eight Charged with Illegally Harvesting and Selling Striped Bass By www.justice.gov Published On :: Fri, 30 Jan 2009 17:45:58 EST Five commercial fishermen in St. Marys County, Md., a fish wholesaler, its owner and an employee have been charged in Maryland and Washington, D.C., for their role in the illegal harvest, sale, and purchase of hundreds of thousands of pounds of striped bass from the Chesapeake Bay and Potomac River from 2003 through 2007. Full Article OPA Press Releases
tri Patriot Coal to Pay $6.5 Million to Settle Clean Water Act Violations By www.justice.gov Published On :: Thu, 5 Feb 2009 11:13:48 EST Patriot Coal Corporation, one of the largest coal mining companies in the United States, has agreed to pay a $6.5 million civil penalty to settle violations of the Clean Water Act. Full Article OPA Press Releases
tri Arizona Man Sentenced to Five Years for Distribution of Child Pornography By www.justice.gov Published On :: Tue, 10 Feb 2009 16:37:16 EST Theodore Allan, 54, of Glendale, Ariz., was sentenced today to five years in prison for distribution of child pornography. Allan was indicted on charges of distribution, receipt and possession of child pornography on March 6, 2007. Full Article OPA Press Releases
tri District of Columbia Seafood Company, Owner and Employee Plead Guilty to Federal Trafficking Charges By www.justice.gov Published On :: Thu, 12 Feb 2009 14:27:13 EST A fish wholesaler, its owner and an employee have all pleaded guilty in U.S. District Court for the District of Columbia for the illegal purchase and sale of striped bass from the Chesapeake Bay and Potomac River from 2003 through 2007. Full Article OPA Press Releases
tri Five Maryland Commercial Fishermen Plead Guilty to Illegally Overfishing Striped Bass By www.justice.gov Published On :: Thu, 19 Feb 2009 17:53:41 EST Five St. Marys County, Md., commercial fisherman pleaded guilty today to illegally overfishing striped bass also known as rockfish. Full Article OPA Press Releases
tri U.S. District Court Judge Pleads Guilty to Obstruction of Justice By www.justice.gov Published On :: Mon, 23 Feb 2009 15:50:16 EST U.S. District Judge Samuel B. Kent pleaded guilty today to obstruction of justice in federal court in Houston. Kent, 59, a district judge in the Southern District of Texas, pleaded guilty to making false statements to a special investigative committee of the U.S. Court of Appeals for the Fifth Circuit during an investigation of a judicial misconduct complaint filed against him. Full Article OPA Press Releases
tri N.J. Electrical Company Employee Pleads Guilty to Defrauding the Environmental Protection Agency at Superfund Site By www.justice.gov Published On :: Thu, 26 Feb 2009 12:31:51 EST An employee of a Sewell, N.J., company that provided temporary electrical utilities pleaded guilty today to participating in a fraud conspiracy at an Environmental Protection Agency (EPA)-designated Superfund site in New Jersey. Full Article OPA Press Releases
tri Justice Department Files Lawsuit Against Wagner Industrial Electric Inc., to Enforce the Employment Rights of Indiana Army National Guardsman By www.justice.gov Published On :: Fri, 27 Feb 2009 12:43:40 EST The Department announced today that it has filed a lawsuit on behalf of Kevin Stenger, an Indiana National Guard member, against Wagner Industrial Electric Inc. (Wagner), alleging violations of the Uniformed Services Employment and Reemployment Rights Act of 1994 (USERRA). USERRA was enacted in 1994 to protect service members from being disadvantaged in their civilian careers due to serving in the uniformed services. Full Article OPA Press Releases
tri N.J. Industrial Pipes Supply Company and Its Co-Owner Plead Guilty to Fraud at Two N.J. Superfund Sites By www.justice.gov Published On :: Wed, 4 Mar 2009 13:13:37 EST A Middlesex, N.J., industrial pipes, valves and fittings supply company and its co-owner pleaded guilty today to participating in a fraud conspiracy at two U.S. Environmental Protection Agency (EPA)-designated Superfund sites in New Jersey. The sites are Federal Creosote, located in Manville, N.J., and Diamond Alkali, located in Newark, N.J. Full Article OPA Press Releases
tri Wisconsin Man Who Participated in 1943 Massacre of 8,000 Jews Is Deported to Austria By www.justice.gov Published On :: Thu, 19 Mar 2009 11:10:58 EDT A former Nazi concentration camp guard who settled in Racine, Wis., after World War II and acquired U.S. citizenship, has been removed to Austria due to his participation in Nazi-sponsored acts of persecution during World War II. Josias Kumpf, 83, served as an armed SS Deaths Head guard at the Nazi-run Sachsenhausen Concentration Camp in Germany and at the Trawniki Labor Camp in Poland. Full Article OPA Press Releases
tri Hurricane Katrina Contractor Accepts $4 Million Judgment Under the False Claims Act By www.justice.gov Published On :: Fri, 24 Apr 2009 12:40:38 EDT The United States has settled its claims filed under the False Claims Act against Lighthouse Disaster Relief and its partners, Gary Heldreth and Kerry Farmer. In its complaint, which was filed in the U.S. District Court for the Middle District of Louisiana, the United States alleged that Lighthouse, Heldreth, and Farmer accepted a $5.3 million payment for work that was not completely performed on a contract with the Department of Homeland Security. Full Article OPA Press Releases
tri U.S. District Court Judge Sentenced to 33 Months in Prison for Obstruction of Justice By www.justice.gov Published On :: Mon, 11 May 2009 15:30:55 EDT U.S. District Judge Samuel B. Kent was sentenced today to 33 months in prison for obstruction of justice related to an investigation of a judicial misconduct complaint filed against him. Full Article OPA Press Releases
tri Justice Department Settles Lawsuit Against Wagner Industrial Electric Inc. to Enforce the Employment Rights of Indiana Reservist By www.justice.gov Published On :: Tue, 19 May 2009 09:29:53 EDT The Department has entered into a consent decree with Wagner Industrial Electric Inc. that, if approved by the court, will resolve the Department’s complaint the company failed to properly reemploy Indiana Army National Guard Reservist Kevin Stenger in violation of the Uniformed Services Employment and Reemployment Rights Act of 1994 (USERRA). Full Article OPA Press Releases
tri North Dakota Executive Pleads Guilty to Nine Counts of Tax Fraud on Eve of Trial By www.justice.gov Published On :: Fri, 29 May 2009 16:38:39 EDT Michael Fisher, owner of Fisher Sand & Gravel Co. Inc. (FSG), based in Dickinson, N.D., today pleaded guilty to nine felony counts of tax fraud. Full Article OPA Press Releases
tri Northwest Indiana Businessman Who Used Sham Trusts Pleads Guilty to Tax Fraud on Eve of Trial By www.justice.gov Published On :: Wed, 3 Jun 2009 11:02:50 EDT Donald Sikma, a businessman from Dyer, Ind., has pleaded guilty to filing a false tax return. Sikma, whose trial was scheduled to begin today, entered his guilty plea Monday before Judge Theresa L. Springmann in Fort Wayne, Ind. Full Article OPA Press Releases
tri Department Asks Alaska Corruption Cases Be Remanded to District Court, Former State Representatives Be Released By www.justice.gov Published On :: Thu, 4 Jun 2009 17:05:26 EDT The Department of Justice today asked the U.S. Court of Appeals for the Ninth Circuit to remand the cases of former Alaska State Representatives Victor Kohring and Peter Kott, who were convicted on corruption charges in 2007, to the District Court. Full Article OPA Press Releases
tri Former District of Columbia Police Officer Pleads Guilty to Tax Charges By www.justice.gov Published On :: Tue, 9 Jun 2009 15:21:00 EDT Willie Borden, a former Washington, D.C., Metropolitan Police Department officer, pleaded guilty today to a criminal tax charge before U.S. District Court Judge James Robertson. Full Article OPA Press Releases
tri City of Duluth, Minnesota, and Western Lake Superior Sanitary District Agree to Eliminate Sewer Overflows By www.justice.gov Published On :: Tue, 23 Jun 2009 16:12:17 EDT The city of Duluth, Minn., and the Western Lake Superior Sanitary District have agreed to make improvements to the areas sewer system, estimated to cost about $130 million, to eliminate sanitary sewer overflows in an agreement filed today in U.S. District Court in Minneapolis, Minn. Full Article OPA Press Releases
tri Medicare Fraud Strike Force Operations Lead to Charges Against 53 Doctors, Health Care Executives and Beneficiaries for More Than $50 Million in Alleged False Billing in Detroit By www.justice.gov Published On :: Wed, 24 Jun 2009 12:47:32 EDT As demonstrated by todays charges and arrests, we will strike back against those whose fraudulent schemes not only undermine a program upon which 45 million aged and disabled Americans depend, but which also contribute directly to rising health care costs that all Americans must bear, said Attorney General Holder. Full Article OPA Press Releases